Skip to content

Site updates

A running log of data refreshes, structured data tweaks, and new educational content rolling out on PsychMed.

Subscribe via RSS

Antidepressant and MAOI coverage added

Loaded seeds for the SSRI/SNRI cohort plus vilazodone, vortioxetine, bupropion, mirtazapine, maprotiline, protriptyline, phenelzine, tranylcypromine, and both oral and transdermal selegiline so every agent now includes label metadata, brands, and TDM flags where applicable.

Mood stabilizers and VMAT2 inhibitors onboarded

Lithium, valproate, carbamazepine, lamotrigine, oxcarbazepine, valbenazine, and deutetrabenazine now ship with DailyMed links, monitoring guidance, and TDM ranges pulled directly from the seed data.

Core antipsychotic catalog published

Initial release includes haloperidol, risperidone, paliperidone, olanzapine, quetiapine, brexpiprazole, cariprazine, lurasidone, lumateperone, ziprasidone, asenapine, and clozapine with label-derived PK, monitoring, and risk flags.